Quick Search 
Drugs of the Future
Register or sign in

Volume 36, Issue 10, October 2011, Pages 735-804
 Daclatasvir dihydrochloride.
Treatment of hepatitis C virus, HCV NS5A inhibitor.
Reviriego, C.
Drugs Fut 2011, 36(10): 735
Summary | Full Text: HTMLPDF 
TNF-α production inhibitor, Treatment of multiple myeloma, Treatment of myelofibrosis.
Galustian, C., Dalgleish, A.G.
Drugs Fut 2011, 36(10): 741
Summary | Full Text: HTMLPDF 
Macrolide antibiotic.
Fernandes, P., Pereira, D., Jamieson, B., Keedy, K.
Drugs Fut 2011, 36(10): 751
Summary | Full Text: HTMLPDF 
 Exploring closed-loop artificial pancreas use in type 1 diabetes.
Strack, T.R.
Drugs Fut 2011, 36(10): 759
Summary | Full Text: HTMLPDF 
 The use of tumor-associated antigens in prostate cancer vaccines.
Amato, R.J., Stepankiw, M.
Drugs Fut 2011, 36(10): 771
Summary | Full Text: HTMLPDF 
 American Diabetes Association – 71st Scientific Sessions (June 24-28, 2011, San Diego, CA, USA).
Croasdell, G.
Drugs Fut 2011, 36(10): 777
Summary | Full Text: HTMLPDF 
 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2011 – focus on first-in-human and phase I trials.
Vasiliou, S., Cole, P., Gomez-Zaera, M.
Drugs Fut 2011, 36(10): 783
Summary | Full Text: HTMLPDF 
 New perspectives on transporters in drug discovery and development: ADME and beyond – highlights from the Society for Medicines Research Symposium (June 23, 2011).
Allen, J., Fish, P.V., Jeffrey, P.
Drugs Fut 2011, 36(10): 793
Summary | Full Text: HTMLPDF 
 World Vaccine Congress Asia 2011 (June 20-24, 2011, Singapore).
Petrovsky, N.
Drugs Fut 2011, 36(10): 801
Full Text: HTMLPDF 

© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy